View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Medical Crossfire®: How Can We Maximize Immuno-Oncology Strategies in Small Cell Lung Cancers?

Medical Crossfire®: How Can We Maximize Immuno-Oncology Strategies in Small Cell Lung Cancers?

Friday, June 19, 2020

Live webcast: 8:00 PM – 10:00 PM ET


Small cell lung cancer (SCLC) is an aggressive form of the disease that comprises 15% of all new lung cancer cases diagnosed each year. Outcomes for patients with SCLC are poor with a median survival of less than 1 year. However, there have been recent advances in our understanding of resistance mechanisms and immune pathways in SCLC and treatment strategies are being actively investigated in clinical trials for this disease.

This live webcast is intended to provide a comprehensive update on the role of immune-oncology in the management of patients with SCLC. Our panel of expert oncologists will discuss a range of pertinent topics including the biologic and clinical rational for IO therapy in SCLC, the role of checkpoint inhibitors in both newly diagnosed extensive stage SCLC and in subsequent lines of therapy. The activity will also include a Medical Crossfire® panel discussion to investigate practical issues and safety concerns as well as future prospects of immunotherapy in SCLC.

Benefits of Attending

  • Hear expert perspectives on the best strategies for combining immunotherapy with chemotherapy for the treatment of SCLC patients
  • Integrate results from the latest clinical studies into your practice decision-making
  • Evaluate safety considerations of immunotherapy in SCLC
  • Outline the latest strategies for the use of immunotherapy in patients with newly diagnosed and previously treated SCLC

Acknowledgement of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Target Audience

This educational program is directed toward the ASCO audience, primarily medical oncologists. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer are also invited to participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Apply efficacy and safety data from recent trials with immunotherapy in patients with SCLC in multiple lines of therapy
  • Discuss strategies to mitigate and manage immune-related adverse events in patients with SCLC
  • Evaluate immunotherapeutic approaches in conjunction with combined modality therapy for patients with limited-stage SCLC
  • Assess biomarkers and techniques in development to optimize selection of patients with SCLC for immunotherapy

Program Chair

Roy Herbst, MD, PhD
Roy Herbst, MD, PhD
Ensign Professor of Medicine (Medical Oncology)
Professor of Pharmacology
Chief of Medical Oncology
Associate Director for Translational Research
Yale Cancer Center
Yale School of Medicine
New Haven, CT


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By